PwC Canada's healthcare team surveyed nearly 2,500 Canadians to give them with the opportunity to share opinions and ideas on the future of health care in Canada. This report helps identify how emerging delivery channels can be developed to address what Canadians need and want, while reducing costs.
In the fifth issue, we explore how medical technology companies can adapt to the changing marketplace by adopting a new business model that focuses on the entire patient experience instead of just episodes of care.
This executive summary provides an overview of Spain's key healthcare issues in 2013.
China recently introduced its 12th Five-Year Plan, which reinforces the government's commitment to easing ownership requirements. This 10Minutes discusses opportunities that private and foreign providers, payers, and investors can adopt to build a presence in China's growing healthcare market.
This PwC case study details the design and launch of an innovative partnership to dramatically improve delivery of healthcare in Lesotho in southern Africa.
PwC's mHealth explores the current state of interoperable systems, why they are so important to mhealth, and how open systems can benefit providers, payers and new device entrants.
Regulatory bodies in the United States and the European Union are beginning to increase scrutiny over mHealth solutions but over 150 countries have yet to develop regulatory frameworks or guidance.
In our CEO Survey, healthcare CEOs told us they’re engaging more with stakeholders like patients, employees, and social media users. Cost-cutting is a focus too.
This report covers five case studies that were examined during PwC's 'Bending the Cost Curve' roundtable, and the probing themes and questions that were debated. The report describes leading practices in the areas of: health system reform; public-private collaboration; HIT and interoperability; and benchmarking for long-term care.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 3Q 2012 edition focuses on recent developments and feedback from our global client base supporting increasing globalisation of the healthcare services sector.
In this second issue, we discuss ways pharmaceutical and medical device companies are using mobility to engage internal and external stakeholders and what elements need to be in place for an effective mHealth strategy.
As developed and emerging economies contend with increasing demand for healthcare services, they face a common challenge: how to manage the escalating costs while increasing access and quality.
This first installment explores how mHealth is enabling a new paradigm where applications use artificial intelligence to simulate the decision-making process, and the challenges developers must overcome to ensure solutions are useful for patients.
To gain perspective on this emerging market, PwC surveyed 18 medical technology companies representing more than 40% of the industry’s India market as well as interviewing 15 executives about the experiences and approaches that have made their businesses successful in India.
The publication provides an outline of Malta`s key healthcare activity indicators. It focuses on healthcare facilities, setting out recent trends in the number of hospital beds, operating theatres, human resources and their utilisation.
As governments grapple with budget constraints, ageing populations, chronic disease and technological development, the need for alternative methods of financing and care delivery intensifies. Ultimately the scope and structure of health PPPs reflect specific needs and context. While some countries seek to add new beds, others require skills that are in short supply in the local/regional economy. In these two articles, we look at the rationale and drivers for healthcare PPPs and specifically how the PPP model is used in Canada and Latin America.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 2Q 2012 edition focuses on the rapid pace of M&A activity in the key healthcare M&A emerging markets of Brazil and China.
This piece describes the challenges and opportunities every foreign or Mexican executive who wants to do business in this opportunistic but complex sector of the economy should know.
PwC report shows developed and emerging markets see mHealth's potential to transform healthcare innovation, but resistance to change could be a barrier.
Through mobile, patients and clinicians can check if a drug is counterfeit by sending a short message service to a server which verifies if a drug is real or fake.
mHealth can give chronic patients customised tools and behaviour information to take control of their condition, make better decisions, and improve their lives.
What principles are key for mHealth's success? PwC says interoperability, integration, intelligence, socialisation, outcomes and engagement help innovation thrive.
More people in emerging markets have mobile devices, which means mHealth can reach vast numbers of people who are most in need of innovative healthcare services.
An overview of Taiwan's healthcare sector and the challenges and opportunities for market participants. Based on a combination of face-to-face interviews, with prominent Taiwan healthcare experts in both the public and private sectors, and secondary research covering a broad range of sources. Available in English and Chinese.
PwC, a leader in global healthcare consulting, is determined to prove that the impossible is possible: a future with superior—and cost effective—healthcare.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
PwC sponsored a Citizens' Jury of UK residents to talk about the country's National Health Service's challenges and key themes, and to make recommendations for improving the NHS - all of which are compiled here in a report. You can also watch a video to see the participants in action during their "jury deliberations" as citizen ambassadors on this important topic.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
If you could change your health care system, how would you do it? Over the course of three weekends, a panel of Ontario citizens was able to share ideas for how they'd like to change their province's health care system, especially as calls for reform get louder. Here, we break down the issues they discussed each weekend and compile their overall views in a final report.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
How universities manage innovation through disciplined and novel measures.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States? Also available in Japanese.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
How will the business model of healthcare change between 2010 and 2020? Scientific and technological developments will enable individuals to play an active role in care.
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.
Creating a sustainable strategy for the future depends on organizations’ abilities to learn and customize workable solutions within a societal context. PricewaterhouseCoopers has identified transferable lessons within seven key features that will create systems that are built to last.
How do healthcare organisations address issues that ranked high in importance or in which there were significant gaps? This PwC report explores the trends that healthcare organisations need to develop tactics for.
HealthCast 2010: Smaller world, bigger expectations is a research-based examination of the road ahead for healthcare executives in the next decade.
PwC Canada's healthcare team surveyed nearly 2,500 Canadians to give them with the opportunity to share opinions and ideas on the future of health care in Canada. This report helps identify how emerging delivery channels can be developed to address what Canadians need and want, while reducing costs.
In the fifth issue, we explore how medical technology companies can adapt to the changing marketplace by adopting a new business model that focuses on the entire patient experience instead of just episodes of care.
This executive summary provides an overview of Spain's key healthcare issues in 2013.
China recently introduced its 12th Five-Year Plan, which reinforces the government's commitment to easing ownership requirements. This 10Minutes discusses opportunities that private and foreign providers, payers, and investors can adopt to build a presence in China's growing healthcare market.
This PwC case study details the design and launch of an innovative partnership to dramatically improve delivery of healthcare in Lesotho in southern Africa.
PwC's mHealth explores the current state of interoperable systems, why they are so important to mhealth, and how open systems can benefit providers, payers and new device entrants.
Regulatory bodies in the United States and the European Union are beginning to increase scrutiny over mHealth solutions but over 150 countries have yet to develop regulatory frameworks or guidance.
In our CEO Survey, healthcare CEOs told us they’re engaging more with stakeholders like patients, employees, and social media users. Cost-cutting is a focus too.
This report covers five case studies that were examined during PwC's 'Bending the Cost Curve' roundtable, and the probing themes and questions that were debated. The report describes leading practices in the areas of: health system reform; public-private collaboration; HIT and interoperability; and benchmarking for long-term care.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 3Q 2012 edition focuses on recent developments and feedback from our global client base supporting increasing globalisation of the healthcare services sector.
In this second issue, we discuss ways pharmaceutical and medical device companies are using mobility to engage internal and external stakeholders and what elements need to be in place for an effective mHealth strategy.
As developed and emerging economies contend with increasing demand for healthcare services, they face a common challenge: how to manage the escalating costs while increasing access and quality.
This first installment explores how mHealth is enabling a new paradigm where applications use artificial intelligence to simulate the decision-making process, and the challenges developers must overcome to ensure solutions are useful for patients.
To gain perspective on this emerging market, PwC surveyed 18 medical technology companies representing more than 40% of the industry’s India market as well as interviewing 15 executives about the experiences and approaches that have made their businesses successful in India.
The publication provides an outline of Malta`s key healthcare activity indicators. It focuses on healthcare facilities, setting out recent trends in the number of hospital beds, operating theatres, human resources and their utilisation.
As governments grapple with budget constraints, ageing populations, chronic disease and technological development, the need for alternative methods of financing and care delivery intensifies. Ultimately the scope and structure of health PPPs reflect specific needs and context. While some countries seek to add new beds, others require skills that are in short supply in the local/regional economy. In these two articles, we look at the rationale and drivers for healthcare PPPs and specifically how the PPP model is used in Canada and Latin America.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 2Q 2012 edition focuses on the rapid pace of M&A activity in the key healthcare M&A emerging markets of Brazil and China.
This piece describes the challenges and opportunities every foreign or Mexican executive who wants to do business in this opportunistic but complex sector of the economy should know.
PwC report shows developed and emerging markets see mHealth's potential to transform healthcare innovation, but resistance to change could be a barrier.
Through mobile, patients and clinicians can check if a drug is counterfeit by sending a short message service to a server which verifies if a drug is real or fake.
mHealth can give chronic patients customised tools and behaviour information to take control of their condition, make better decisions, and improve their lives.
What principles are key for mHealth's success? PwC says interoperability, integration, intelligence, socialisation, outcomes and engagement help innovation thrive.
More people in emerging markets have mobile devices, which means mHealth can reach vast numbers of people who are most in need of innovative healthcare services.
An overview of Taiwan's healthcare sector and the challenges and opportunities for market participants. Based on a combination of face-to-face interviews, with prominent Taiwan healthcare experts in both the public and private sectors, and secondary research covering a broad range of sources. Available in English and Chinese.
PwC, a leader in global healthcare consulting, is determined to prove that the impossible is possible: a future with superior—and cost effective—healthcare.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
PwC sponsored a Citizens' Jury of UK residents to talk about the country's National Health Service's challenges and key themes, and to make recommendations for improving the NHS - all of which are compiled here in a report. You can also watch a video to see the participants in action during their "jury deliberations" as citizen ambassadors on this important topic.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
If you could change your health care system, how would you do it? Over the course of three weekends, a panel of Ontario citizens was able to share ideas for how they'd like to change their province's health care system, especially as calls for reform get louder. Here, we break down the issues they discussed each weekend and compile their overall views in a final report.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
How universities manage innovation through disciplined and novel measures.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States? Also available in Japanese.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
How will the business model of healthcare change between 2010 and 2020? Scientific and technological developments will enable individuals to play an active role in care.
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.
Creating a sustainable strategy for the future depends on organizations’ abilities to learn and customize workable solutions within a societal context. PricewaterhouseCoopers has identified transferable lessons within seven key features that will create systems that are built to last.
How do healthcare organisations address issues that ranked high in importance or in which there were significant gaps? This PwC report explores the trends that healthcare organisations need to develop tactics for.
HealthCast 2010: Smaller world, bigger expectations is a research-based examination of the road ahead for healthcare executives in the next decade.
PwC Canada's healthcare team surveyed nearly 2,500 Canadians to give them with the opportunity to share opinions and ideas on the future of health care in Canada. This report helps identify how emerging delivery channels can be developed to address what Canadians need and want, while reducing costs.
In the fifth issue, we explore how medical technology companies can adapt to the changing marketplace by adopting a new business model that focuses on the entire patient experience instead of just episodes of care.
This executive summary provides an overview of Spain's key healthcare issues in 2013.
China recently introduced its 12th Five-Year Plan, which reinforces the government's commitment to easing ownership requirements. This 10Minutes discusses opportunities that private and foreign providers, payers, and investors can adopt to build a presence in China's growing healthcare market.
This PwC case study details the design and launch of an innovative partnership to dramatically improve delivery of healthcare in Lesotho in southern Africa.
PwC's mHealth explores the current state of interoperable systems, why they are so important to mhealth, and how open systems can benefit providers, payers and new device entrants.
Regulatory bodies in the United States and the European Union are beginning to increase scrutiny over mHealth solutions but over 150 countries have yet to develop regulatory frameworks or guidance.
In our CEO Survey, healthcare CEOs told us they’re engaging more with stakeholders like patients, employees, and social media users. Cost-cutting is a focus too.
This report covers five case studies that were examined during PwC's 'Bending the Cost Curve' roundtable, and the probing themes and questions that were debated. The report describes leading practices in the areas of: health system reform; public-private collaboration; HIT and interoperability; and benchmarking for long-term care.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 3Q 2012 edition focuses on recent developments and feedback from our global client base supporting increasing globalisation of the healthcare services sector.
In this second issue, we discuss ways pharmaceutical and medical device companies are using mobility to engage internal and external stakeholders and what elements need to be in place for an effective mHealth strategy.
As developed and emerging economies contend with increasing demand for healthcare services, they face a common challenge: how to manage the escalating costs while increasing access and quality.
This first installment explores how mHealth is enabling a new paradigm where applications use artificial intelligence to simulate the decision-making process, and the challenges developers must overcome to ensure solutions are useful for patients.
To gain perspective on this emerging market, PwC surveyed 18 medical technology companies representing more than 40% of the industry’s India market as well as interviewing 15 executives about the experiences and approaches that have made their businesses successful in India.
The publication provides an outline of Malta`s key healthcare activity indicators. It focuses on healthcare facilities, setting out recent trends in the number of hospital beds, operating theatres, human resources and their utilisation.
As governments grapple with budget constraints, ageing populations, chronic disease and technological development, the need for alternative methods of financing and care delivery intensifies. Ultimately the scope and structure of health PPPs reflect specific needs and context. While some countries seek to add new beds, others require skills that are in short supply in the local/regional economy. In these two articles, we look at the rationale and drivers for healthcare PPPs and specifically how the PPP model is used in Canada and Latin America.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 2Q 2012 edition focuses on the rapid pace of M&A activity in the key healthcare M&A emerging markets of Brazil and China.
This piece describes the challenges and opportunities every foreign or Mexican executive who wants to do business in this opportunistic but complex sector of the economy should know.
PwC report shows developed and emerging markets see mHealth's potential to transform healthcare innovation, but resistance to change could be a barrier.
Through mobile, patients and clinicians can check if a drug is counterfeit by sending a short message service to a server which verifies if a drug is real or fake.
mHealth can give chronic patients customised tools and behaviour information to take control of their condition, make better decisions, and improve their lives.
What principles are key for mHealth's success? PwC says interoperability, integration, intelligence, socialisation, outcomes and engagement help innovation thrive.
More people in emerging markets have mobile devices, which means mHealth can reach vast numbers of people who are most in need of innovative healthcare services.
An overview of Taiwan's healthcare sector and the challenges and opportunities for market participants. Based on a combination of face-to-face interviews, with prominent Taiwan healthcare experts in both the public and private sectors, and secondary research covering a broad range of sources. Available in English and Chinese.
PwC, a leader in global healthcare consulting, is determined to prove that the impossible is possible: a future with superior—and cost effective—healthcare.
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? Our 1Q 2012 edition focuses on investments in the evolving global hospital sector.
PwC sponsored a Citizens' Jury of UK residents to talk about the country's National Health Service's challenges and key themes, and to make recommendations for improving the NHS - all of which are compiled here in a report. You can also watch a video to see the participants in action during their "jury deliberations" as citizen ambassadors on this important topic.
The fourth meeting in our series focused in particular on the challenges faced in emerging economies, highlighting innovative practices and solutions that are transferable from one healthcare system to the next. Healthcare executives and leaders from around the globe will gather in South Africa for this landmark event.
Healthcare CEOs are gloomy about the global economy, but they're diversifying and expanding overseas, showing a more positive outlook for their own organisations.
South East Asia’s evolving health systems are using healthcare public-private partnerships (PPPs) to expand capacity and quality of healthcare in emerging markets.
How we assess value in medical technology is changing. How can countries overcome their weaknesses to develop a system to help medical technology companies thrive?
What are the recent investment trends and opportunities in global healthcare markets and what regions are likely to draw future merger and acquisition activity? This issue focuses on three compelling investment opportunities across the global healthcare provider market.
How can government and private industry be more accountable for healthcare delivery and financing, and how can they achieve greater efficiency in health spending?
To survive the coming storm, biomedical companies must build new models of innovation that are anchored in consumer-centric disease solutions rather than the traditional R&D department approaches.
On 15 November, 2011, PwC, in conjunction with sponsoring organisations – Duke-NUS Graduate Medical School Singapore, McGill University and The Nuffield Trust – convened the third in a series of four symposia called Bending the Cost Curve: Emerging International Best Practices.
If you could change your health care system, how would you do it? Over the course of three weekends, a panel of Ontario citizens was able to share ideas for how they'd like to change their province's health care system, especially as calls for reform get louder. Here, we break down the issues they discussed each weekend and compile their overall views in a final report.
In partnership with the European Hospital and Healthcare Federation (HOPE), this report explores the strategies European hospitals are undertaking to adapt as health systems shift toward more personalised health delivery and medicine.
PwC, in collaboration with McGill University and The Nuffield Trust, hosted the second symposium of Bending the Cost Curve in Amsterdam. About 30 European healthcare leaders participated in roundtable discussions exploring case studies in: wiring-up healthcare; integrated care; precision medicine; hospital efficiency and regulation of healthcare.
To take advantage of the opportunities that healthcare's new products and services offer, businesses need to build innovative business models to provide value.
How universities manage innovation through disciplined and novel measures.
On 2 February 2011, PwC, in conjunction with three sponsoring organizations—the Atlantic Council, McGill University and The Commonwealth Fund—launched Bending the Cost Curve: Emerging International Best Practices. The meeting brought together some of the world’s leading healthcare experts who explored five international case studies, debated the issues and left with lessons learned.
What is the capacity and capability for medical technology innovation in Brazil, China, France, Germany, India, Israel, Japan, United Kingdom, United States? Also available in Japanese.
There is a major phenomenon in the Chinese healthcare marketplace: the explosion of a vigorous and demanding middle class. How does it impact the future directions the industry should pursue?
Mobile technology is changing the way we interact and communicate with each other, but it's yet to pierce the ingrained practices of healthcare. However, mobile health is making headway and creating business models that unlock access to new players and technologies that support preventative, acute and chronic care.
What are the emerging trends from the employer's perspective on the needs, wants, and satisfaction levels of employers regarding health insurance and benefits?
How will the business model of healthcare change between 2010 and 2020? Scientific and technological developments will enable individuals to play an active role in care.
This report looks at the factors driving needed change in healthcare payment systems to meet future demands and leverage incentives to positively change behaviour and outcomes.
Healthcare services demand and expectations are rising. With reform on the agenda, PwC looks at the changing role of the health insurer.
Creating a sustainable strategy for the future depends on organizations’ abilities to learn and customize workable solutions within a societal context. PricewaterhouseCoopers has identified transferable lessons within seven key features that will create systems that are built to last.
How do healthcare organisations address issues that ranked high in importance or in which there were significant gaps? This PwC report explores the trends that healthcare organisations need to develop tactics for.
HealthCast 2010: Smaller world, bigger expectations is a research-based examination of the road ahead for healthcare executives in the next decade.